248 related articles for article (PubMed ID: 38456287)
1. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
Manzo OL; Nour J; Sasset L; Marino A; Rubinelli L; Palikhe S; Smimmo M; Hu Y; Bucci MR; Borczuk A; Elemento O; Freed JK; Norata GD; Di Lorenzo A
Circ Res; 2024 Apr; 134(8):990-1005. PubMed ID: 38456287
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipid Metabolism and Signaling in Endothelial Cell Functions.
Sasset L; Di Lorenzo A
Adv Exp Med Biol; 2022; 1372():87-117. PubMed ID: 35503177
[TBL] [Abstract][Full Text] [Related]
3. Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure.
Sasset L; Manzo OL; Zhang Y; Marino A; Rubinelli L; Riemma MA; Chalasani MLS; Dasoveanu DC; Roviezzo F; Jankauskas SS; Santulli G; Bucci MR; Lu TT; Di Lorenzo A
Cardiovasc Res; 2023 Mar; 119(2):506-519. PubMed ID: 35815623
[TBL] [Abstract][Full Text] [Related]
4. Nogo-B mediates endothelial oxidative stress and inflammation to promote coronary atherosclerosis in pressure-overloaded mouse hearts.
Zhang Y; Li JJ; Xu R; Wang XP; Zhao XY; Fang Y; Chen YP; Ma S; Di XH; Wu W; She G; Pang ZD; Wang YD; Zhang X; Xie W; Deng XL; Du XJ; Zhang Y
Redox Biol; 2023 Dec; 68():102944. PubMed ID: 37890359
[TBL] [Abstract][Full Text] [Related]
5. Effects of sphingolipid metabolism disorders on endothelial cells.
Lai Y; Tian Y; You X; Du J; Huang J
Lipids Health Dis; 2022 Oct; 21(1):101. PubMed ID: 36229882
[TBL] [Abstract][Full Text] [Related]
6. Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure.
Cantalupo A; Zhang Y; Kothiya M; Galvani S; Obinata H; Bucci M; Giordano FJ; Jiang XC; Hla T; Di Lorenzo A
Nat Med; 2015 Sep; 21(9):1028-1037. PubMed ID: 26301690
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload.
Zhang Y; Huang Y; Cantalupo A; Azevedo PS; Siragusa M; Bielawski J; Giordano FJ; Di Lorenzo A
JCI Insight; 2016 Apr; 1(5):. PubMed ID: 27158676
[TBL] [Abstract][Full Text] [Related]
9. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.
Sasset L; Zhang Y; Dunn TM; Di Lorenzo A
Trends Endocrinol Metab; 2016 Nov; 27(11):807-819. PubMed ID: 27562337
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipid Signature of Human Feto-Placental Vasculature in Preeclampsia.
Del Gaudio I; Sasset L; Lorenzo AD; Wadsack C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033121
[TBL] [Abstract][Full Text] [Related]
13. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V
J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142
[TBL] [Abstract][Full Text] [Related]
14. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
15. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
16. Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease.
Song JH; Kim GT; Park KH; Park WJ; Park TS
Biomol Ther (Seoul); 2021 Jul; 29(4):373-383. PubMed ID: 33903284
[TBL] [Abstract][Full Text] [Related]
17. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
18. The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers.
Di Pietro P; Izzo C; Abate AC; Iesu P; Rusciano MR; Venturini E; Visco V; Sommella E; Ciccarelli M; Carrizzo A; Vecchione C
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671552
[TBL] [Abstract][Full Text] [Related]
19. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
